| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 03/15/2011 | US7906528 Such as 5-(2,6-diethyl-phenyl)-1H-pyrrolo[2,3-C]pyridine, which binds C5a receptors with high affinity; for treatment of inflammatory, cardiovascular, and immune system disorders; kits |
| 03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
| 03/15/2011 | CA2396030C Camptothecin .beta.-alanine esters with topoisomerase i inhibition |
| 03/10/2011 | WO2011027805A1 Therapeutic agent for mood disorders |
| 03/10/2011 | US20110060140 Synthesis of (+) cortistatin a and related compounds |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | CA2771327A1 Chemical compounds |
| 03/09/2011 | EP2292615A1 Quinazoline compounds |
| 03/09/2011 | EP2291382A1 Time temperature indicator comprising indolenin based spiropyrans containing a n-acetylamido or n- acetylester side chain |
| 03/09/2011 | EP2291381A1 Novel 2-substituted quinoline derivatives, and method for preparing same |
| 03/09/2011 | EP2109615B1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 03/08/2011 | US7902205 Purinone derivatives as HM74A agonists |
| 03/08/2011 | US7901812 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge |
| 03/08/2011 | CA2449217C Process for cleaning hard gelatine capsules |
| 03/08/2011 | CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/03/2011 | WO2011025947A1 Raf inhibitor compounds and methods of use thereof |
| 03/03/2011 | WO2010145197A8 Novel 6-arylamino pyridone sulfonamides and 6-arylamino pyrazinone sulfonamdies as mek inhibitors |
| 03/03/2011 | US20110055943 Novel therapeutic targets in inflammatory bowel disease |
| 03/03/2011 | US20110054165 Xanthene dyes |
| 03/03/2011 | US20110053974 Carboxylic acid compound |
| 03/03/2011 | US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 03/03/2011 | US20110053922 Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists |
| 03/03/2011 | US20110053912 Pyrimidine compound |
| 03/03/2011 | US20110053282 Methods and Kits Using Extended Rhodamine Dyes |
| 03/03/2011 | CA2771893A1 Raf inhibitor compounds and methods of use thereof |
| 03/02/2011 | EP2289890A1 Compounds for the treatment of multi-drug resistant bacterial infections |
| 03/02/2011 | EP2289868A1 Carboxylic acid compound |
| 03/02/2011 | EP2288596A2 Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use |
| 03/02/2011 | CN101983202A Luminescence quenchers and fluorogenic probes for detection of reactive species |
| 03/02/2011 | CN101983201A Optically active dibenzazepine derivatives |
| 03/01/2011 | US7897647 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 03/01/2011 | US7897638 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules |
| 03/01/2011 | US7897635 HIV protease inhibitors |
| 03/01/2011 | US7897634 Pyrazoles for the treatment of obesity and other CNS disorders |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897596 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina |
| 03/01/2011 | US7897387 Fungal cell wall synthesis gene |
| 03/01/2011 | CA2530001C Polymer |
| 02/24/2011 | WO2011022694A2 Furanopyrimidine cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011022692A2 Furanopyridine cannabinoid compounds and related methods of use |
| 02/24/2011 | WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | WO2011021038A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors |
| 02/24/2011 | WO2011020193A1 Renin inhibitors |
| 02/24/2011 | WO2010149944A8 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer |
| 02/24/2011 | US20110046393 Process for producing trans-dibenzoxenopyrrole compound and intermediate therefor |
| 02/24/2011 | US20110046176 Furanopyridine cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046175 Benzofuran cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046171 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 02/24/2011 | US20110046163 Furanopyrimidine cannabinoid compounds and related methods of use |
| 02/24/2011 | US20110046161 Hcv ns3 protease inhibitors |
| 02/24/2011 | US20110046097 Substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/24/2011 | CA2771594A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors |
| 02/24/2011 | CA2771579A1 Nitrogen-containing compound and pharmaceutical composition |
| 02/23/2011 | EP2286844A2 Antibody-drug conjugates and methods |
| 02/23/2011 | EP2286812A1 Solubilized topoisomerase poisons |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | CN101981038A Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors |
| 02/23/2011 | CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 02/23/2011 | CN101979392A 7-arylethylene substituted high camptothecin compound and application thereof as medicament |
| 02/22/2011 | US7893266 Detection of cancer cells in vitro using sigma-2 receptor ligands as radiotracers |
| 02/22/2011 | US7893256 Azabicycloalkane compounds |
| 02/22/2011 | US7893160 Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon |
| 02/22/2011 | US7893098 Pyrrole and pyrazole DAAO inhibitors |
| 02/22/2011 | US7893090 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 02/22/2011 | US7893086 Sirtuin modulating compounds |
| 02/22/2011 | US7893084 Viral polymerase inhibitors |
| 02/22/2011 | US7893082 Substituted tetrahydroquinolines |
| 02/22/2011 | US7893067 Cysteine protease inhibitors |
| 02/22/2011 | CA2624558C Cross-linked cyclic amine compounds and agents for pest control |
| 02/22/2011 | CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents |
| 02/22/2011 | CA2484159C Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase |
| 02/22/2011 | CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 02/22/2011 | CA2329181C 12,13-modified epothilone derivatives |
| 02/22/2011 | CA2263409C High molecular weight polymer-based prodrugs |
| 02/17/2011 | WO2011019060A1 Hedgehog signal inhibitor |
| 02/17/2011 | WO2011018384A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation |
| 02/17/2011 | WO2011017998A1 Gambogic acid cyclization analogues, preparation method and application thereof |
| 02/17/2011 | US20110039862 Protease Inhibitors |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039836 Tricyclic antibiotics |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039823 Oxazolidinone antibiotics |
| 02/17/2011 | CA2770724A1 Compounds and methods of use thereof |
| 02/17/2011 | CA2769761A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation |
| 02/16/2011 | EP2283898A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2283004A1 Amido-thiophene compounds and their use |
| 02/16/2011 | EP1896481B1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | CN101977916A 4'4'-dioxaspiro-spirocyclic substituted tetramates |
| 02/16/2011 | CN101974005A Preparation method of high-content sesquiterpenoids tripterygium alkaloid |
| 02/16/2011 | CN101974004A Heterocyclic compound and preparation method thereof |
| 02/16/2011 | CN101974003A Method for extracting corynoline |
| 02/16/2011 | CN101974002A Naphthapyran derivative containing sulfonamide groups |
| 02/16/2011 | CN101974001A Process for extracting pure liriodenine from Chinese tuliptree barks |
| 02/16/2011 | CN101973996A Imide biotin intermediate monoester and preparation method and use thereof |
| 02/16/2011 | CN101407520B Use of aporphine alkaloid and derivative in preparing anti-figus medicine |